Loading...

John Mills

Title(s)Professor, Medicine
SchoolSchool of Medicine
AddressLocation Required
Varies CA 00000
Phone--
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency Internal Medicine
    Collapse Awards and Honors
    American Society for Microbiology201040 Year Commendation
    Royal Australian College of Physicians2010Life Membership
    Royal Australian College of Physicians2003Wunderly Oration & Medal
    Royal Australian College of Physicians1996Kincaid Smith Oration and Medal
    USPHS-NIH-NIAID 1990Certificate of Appreciation

    Collapse Research 
    Collapse Research Activities and Funding
    MOLECULAR BASIS OF DRUG RESISTANCE IN PLASMODIA
    NIH F06TW001693Jul 11, 1992
    Role: Principal Investigator
    ADULT AIDS CLINICAL TRIALS UNIT
    NIH U01AI027663Mar 1, 1992 - Dec 31, 2006
    Role: Co-Principal Investigator
    UCSF AIDS RESEARCH TRAINING PROGRAM
    NIH T32AI007395Aug 1, 1990 - Jul 31, 2005
    Role: Co-Principal Investigator
    NEUROPEPTIDE INTERACTIONS WITH HIV-INFECTED MACROPHAGES
    NIH R01DK041059Mar 1, 1989 - Feb 29, 1992
    Role: Principal Investigator
    HERPES VIRUS INFECTION IN AN IMMUNOLOGIC MODEL
    NIH R01AI025157Sep 1, 1987 - Aug 31, 1990
    Role: Principal Investigator
    ROLE OF MACROPHAGES IN THE PATHOGENESIS OF HIV INFECTION
    NIH R01AI025329Sep 1, 1987 - Aug 31, 1990
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021 Jan 13. Joyner MJ, Carter RE, Senefeld JW, Klassen SA, Mills JR, Johnson PW, Theel ES, Wiggins CC, Bruno KA, Klompas AM, Lesser ER, Kunze KL, Sexton MA, Diaz Soto JC, Baker SE, Shepherd JRA, van Helmond N, Verdun NC, Marks P, van Buskirk CM, Winters JL, Stubbs JR, Rea RF, Hodge DO, Herasevich V, Whelan ER, Clayburn AJ, Larson KF, Ripoll JG, Andersen KJ, Buras MR, Vogt MNP, Dennis JJ, Regimbal RJ, Bauer PR, Blair JE, Paneth NS, Fairweather D, Wright RS, Casadevall A. PMID: 33523609.
      View in: PubMed   Mentions: 8     Fields:    
    2. Keystone Island Flap: Effects of Islanding on Vascularity. Plast Reconstr Surg Glob Open. 2016 Feb; 4(2):e617. Lo CH, Nottle T, Mills J. PMID: 27014546.
      View in: PubMed   Mentions:
    3. Quantitative Assessment of Intra-Patient Variation in CD4+ T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected Subjects. PLoS One. 2015; 10(6):e0125248. Gordon CL, Cheng AC, Cameron PU, Bailey M, Crowe SM, Mills J. PMID: 26110761.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    4. Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med. 2015 Apr; 4(4):389-400. Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J, Baty R, Graziano EI, Proto Marco B, Caron A, Sköld P, Andrews PW, Baxter MA, Hay DC, Hamdam J, Sharpe ME, Patel S, Jones DR, Reinhardt J, Danen EH, Ben-David U, Stacey G, Björquist P, Piner J, Mills J, Rowe C, Pellegrini G, Sethu S, Antoine DJ, Cross MJ, Murray P, Williams DP, Kitteringham NR, Goldring CE, Park BK. PMID: 25722427.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    5. Multiparametric 3T MRI in the evaluation of intraglandular prostate cancer: correlation with histopathology. J Med Imaging Radiat Oncol. 2014 Aug; 58(4):439-48. Styles C, Ferris N, Mitchell C, Murphy D, Frydenberg M, Mills J, Pedersen J, Bergen N, Duchesne G. PMID: 24935089.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    6. A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease. Cancer Med. 2014 Oct; 3(5):1266-74. Severi G, FitzGerald LM, Muller DC, Pedersen J, Longano A, Southey MC, Hopper JL, English DR, Giles GG, Mills J. PMID: 24909936.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    7. An unusual case of HIV virologic failure during treatment with boosted atazanavir. AIDS. 2013 May 15; 27(8):1361-2. Duncan A, Mills J. PMID: 23925384.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    8. No association between XMRV or related gammaretroviruses in Australian prostate cancer patients. Virol J. 2013 Jan 10; 10:20. Rezaei SD, Hearps AC, Mills J, Pedersen J, Tachedjian G. PMID: 23305518.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    9. Utility of RhoC and ZAG protein expression as biomarkers for prediction of PSA failure following radical prostatectomy for high grade prostate cancer. Pathology. 2012 Oct; 44(6):513-8. Mills J, Oliver A, Sherwin JC, Frydenberg M, Peters JS, Costello A, Harewood L, Love C, Redgrave N, van Golen KL, Bailey M, Pedersen J. PMID: 22935975.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Protein-protein interactions in RSV assembly: potential targets for attenuating RSV strains. Infect Disord Drug Targets. 2012 Apr; 12(2):103-9. Ghildyal R, Jans DA, Bardin PG, Mills J. PMID: 22335497.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    11. Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysis. Pathology. 2012 Apr; 44(3):204-8. Kerger M, Hong MK, Pedersen J, Nottle T, Ryan A, Mills J, Peters JS, Moon D, Crowe H, Costello AJ, Corcoran NM, Hovens CM. PMID: 22406482.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. RSV research is now close to providing solutions to RSV infection. Infect Disord Drug Targets. 2012 Apr; 12(2):91. Ghildyal R, Mills J. PMID: 22335495.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    13. HIV infection and aging of the innate immune system. Sex Health. 2011 Dec; 8(4):453-64. Hearps AC, Angelovich TA, Jaworowski A, Mills J, Landay AL, Crowe SM. PMID: 22127030.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    14. Improved detection of mycobacteria species in formalin-fixed tissue sections. Histopathology. 2011 Nov; 59(5):993-1005. Pedersen JS, Clarke I, Mills J. PMID: 22092411.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    15. A new preoperative nomogram to predict minimal prostate cancer: accuracy and error rates compared to other tools to select patients for active surveillance. J Urol. 2011 Nov; 186(5):1811-7. O'Brien BA, Cohen RJ, Ryan A, Sengupta S, Mills J. PMID: 21944097.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. Tumor volume in radical prostatectomy specimens assessed by digital image analysis software correlates with other prognostic factors. J Urol. 2010 May; 183(5):1808-14. Sherwin JC, Mirmilstein G, Pedersen J, Lawrentschuk N, Bolton D, Mills J. PMID: 20303103.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    17. Epidemiology of primary brain tumors in the Middle Eastern population in California, USA 2001-2005. Cancer Detect Prev. 2009; 32(5-6):363-71. Nasseri K, Mills JR. PMID: 19588542.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008 Oct 23; 359(17):1846; author reply 1846-7. Mills J. PMID: 18949841.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    19. Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein. J Virol. 2008 Sep; 82(17):8863-70. Li D, Jans DA, Bardin PG, Meanger J, Mills J, Ghildyal R. PMID: 18579594.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    20. Phase 1 single dose studies to optimize the pharmacokinetics of DG17, a novel HIV-protease inhibitor pro-drug, using sodium bicarbonate and ritonavir. Curr HIV Res. 2008 May; 6(3):272-5. Cherry CL, Hoy JF, Rowe JS, Krum H, Mills J, Lewin SR. PMID: 18473792.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    21. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology. 2007 Sep 23; 4:66. Gorry PR, McPhee DA, Verity E, Dyer WB, Wesselingh SL, Learmont J, Sullivan JS, Roche M, Zaunders JJ, Gabuzda D, Crowe SM, Mills J, Lewin SR, Brew BJ, Cunningham AL, Churchill MJ. PMID: 17888184.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    22. Adverse effects of antiretroviral drugs on HIV-1-infected and -uninfected human monocyte-derived macrophages. . 2006 May; 42(1):19-28. Azzam R, Lal L, Goh SL, Kedzierska K, Jaworowski A, Naim E, Cherry CL, Wesselingh SL, Mills J, Crowe SM. PMID: 16639337.
      View in: PubMed   Mentions:
    23. Quantitation of chromosome 1p and 19q deletions in glial tumours by interphase FISH on formalin-fixed paraffin-embedded tissue. J Clin Neurosci. 2006 Jan; 13(1):96-101. Gonzales M, Dale S, Susman M, Mills J. PMID: 16410204.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    24. Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J Gen Virol. 2005 Jul; 86(Pt 7):1879-1884. Ghildyal R, Li D, Peroulis I, Shields B, Bardin PG, Teng MN, Collins PL, Meanger J, Mills J. PMID: 15958665.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    25. In vivo replication kinetics of a nef-deleted strain of HIV-1. AIDS. 2005 May 20; 19(8):842-3. Crowe SM, Ho DD, Marriott D, Brew B, Gorry PR, Sullivan JS, Learmont J, Mills J. PMID: 15867504.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    26. Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia. J Infect Dis. 2004 Dec 15; 190(12):2181-6. Churchill M, Sterjovski J, Gray L, Cowley D, Chatfield C, Learmont J, Sullivan JS, Crowe SM, Mills J, Brew BJ, Wesselingh SL, McPhee DA, Gorry PR. PMID: 15551218.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    27. Sequence and structure relatedness of matrix protein of human respiratory syncytial virus with matrix proteins of other negative-sense RNA viruses. Clin Microbiol Infect. 2004 Oct; 10(10):945-8. Latiff K, Meanger J, Mills J, Ghildyal R. PMID: 15373896.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    28. Multiple heparin binding domains of respiratory syncytial virus G mediate binding to mammalian cells. Arch Virol. 2003 Oct; 148(10):1987-2003. Shields B, Mills J, Ghildyal R, Gooley P, Meanger J. PMID: 14551820.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    29. Association of matrix protein of respiratory syncytial virus with the host cell membrane of infected cells. Arch Virol. 2004 Jan; 149(1):199-210. Marty A, Meanger J, Mills J, Shields B, Ghildyal R. PMID: 14689285.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    30. The matrix protein of Human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch Virol. 2003 Jul; 148(7):1419-29. Ghildyal R, Baulch-Brown C, Mills J, Meanger J. PMID: 12827470.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    31. Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev. 2003 Apr-Jun; 5(2):113-25. Blower S, Schwartz EJ, Mills J. PMID: 12876900.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    32. Current research on respiratory viral infections: Fourth International Symposium. Antiviral Res. 2002 Aug; 55(2):227-78. Ison MG, Mills J, Openshaw P, Zambon M, Osterhaus A, Hayden F. PMID: 12103428.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsPHPublic Health
    33. Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence. J Virol. 2002 Jul; 76(14):6966-73. Jekle A, Schramm B, Jayakumar P, Trautner V, Schols D, De Clercq E, Mills J, Crowe SM, Goldsmith MA. PMID: 12072497.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    34. Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol. 2002 Apr; 83(Pt 4):753-757. Ghildyal R, Mills J, Murray M, Vardaxis N, Meanger J. PMID: 11907323.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    35. Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J Virol. 2002 Mar; 76(6):2692-702. Greenway AL, McPhee DA, Allen K, Johnstone R, Holloway G, Mills J, Azad A, Sankovich S, Lambert P. PMID: 11861836.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    36. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol. 2001 Oct; 22(3):263-70. Birch MR, Learmont JC, Dyer WB, Deacon NJ, Zaunders JJ, Saksena N, Cunningham AL, Mills J, Sullivan JS. PMID: 11564591.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    37. Specific inhibition of human immunodeficiency virus type 1 (HIV-1) integration in cell culture: putative inhibitors of HIV-1 integrase. Antimicrob Agents Chemother. 2001 Sep; 45(9):2510-6. Vandegraaff N, Kumar R, Hocking H, Burke TR, Mills J, Rhodes D, Burrell CJ, Li P. PMID: 11502522.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    38. Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs. AIDS. 2001 Aug 17; 15(12):1471-5. Dunne AL, Mitchell FM, Coberly SK, Hellmann NS, Hoy J, Mijch A, Petropoulos CJ, Mills J, Crowe SM. PMID: 11504978.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    39. Current research on respiratory viral infections: Third International Symposium. Antiviral Res. 2001 Jun; 50(3):157-96. Schmidt AC, Couch RB, Galasso GJ, Hayden FG, Mills J, Murphy BR, Chanock RM. PMID: 11397506.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    40. nef-deleted HIV-1 inhibits phagocytosis by monocyte-derived macrophages in vitro but not by peripheral blood monocytes in vivo. AIDS. 2001 May 25; 15(8):945-55. Kedzierska K, Mak J, Jaworowski A, Greenway A, Violo A, Chan HT, Hocking J, Purcell D, Sullivan JS, Mills J, Crowe S. PMID: 11399976.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    41. Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety. Proc Natl Acad Sci U S A. 2001 Mar 13; 98(6):3618-23. Blower SM, Koelle K, Kirschner DE, Mills J. PMID: 11248127.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsPHPublic Health
    42. Infectivity of wild-type and deleted proviral SIV DNA. Dev Biol (Basel). 2001; 106:395-406. Purcell DF, Cameron PU, Mills J, Kent S. PMID: 11761255.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    43. Live attenuated HIV vaccines: a proposal for further research and development. AIDS Res Hum Retroviruses. 2000 Oct 10; 16(15):1453-61. Mills J, Desrosiers R, Rud E, Almond N. PMID: 11054258.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsPHPublic Health
    44. Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. J Infect Dis. 1999 Dec; 180(6):2009-13. Ghildyal R, Hartley C, Varrasso A, Meanger J, Voelker DR, Anders EM, Mills J. PMID: 10558959.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    45. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med. 1999 Jun 03; 340(22):1715-22. Learmont JC, Geczy AF, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ, Dyer WB, McIntyre L, Oelrichs RB, Rhodes DI, Deacon NJ, Sullivan JS. PMID: 10352163.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCells
    46. Coresistance to zidovudine and foscarnet is associated with multiple mutations in the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother. 1998 Nov; 42(11):3038-43. Tachedjian G, French M, Mills J. PMID: 9797252.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    47. Impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1998 Aug 10; 14(12):1059-64. Tachedjian G, Mellors JW, Bazmi H, Mills J. PMID: 9718121.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    48. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS. 1998 May 07; 12(7):719-27. Lewin SR, Kirihara J, Sonza S, Irving L, Mills J, Crowe SM. PMID: 9619803.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    49. Serological detection of attenuated HIV-1 variants with nef gene deletions. AIDS. 1998 Apr 16; 12(6):555-61. Greenway AL, Mills J, Rhodes D, Deacon NJ, McPhee DA. PMID: 9583594.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    50. Determination of the disulfide bond arrangement of human respiratory syncytial virus attachment (G) protein by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Protein Sci. 1997 Jun; 6(6):1308-15. Gorman JJ, Ferguson BL, Speelman D, Mills J. PMID: 9194191.
      View in: PubMed   Mentions: 22     Fields:    Translation:Cells
    51. Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages. J Virol. 1997 Mar; 71(3):2114-9. Lewin SR, Lambert P, Deacon NJ, Mills J, Crowe SM. PMID: 9032344.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    52. Detection and subgrouping of respiratory syncytial virus directly from nasopharyngeal aspirates. Clin Microbiol Infect. 1997 Feb; 3(1):120-123. Ghildyal R, Hogg G, Mills J, Meanger J. PMID: 11864086.
      View in: PubMed   Mentions: 3     Fields:    
    53. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J Virol. 1996 Oct; 70(10):6701-8. Greenway A, Azad A, Mills J, McPhee D. PMID: 8794306.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    54. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet. J Virol. 1996 Oct; 70(10):7171-81. Tachedjian G, Mellors J, Bazmi H, Birch C, Mills J. PMID: 8794364.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    55. Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4. J Gen Virol. 1996 Sep; 77 ( Pt 9):2015-23. Hartley CA, Gilbert MJ, Brigido L, Elbeik T, Levy JA, Crowe SM, Mills J. PMID: 8810998.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    56. Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages. AIDS Res Hum Retroviruses. 1996 Jul 01; 12(10):877-83. Lewin SR, Sonza S, Irving LB, McDonald CF, Mills J, Crowe SM. PMID: 8798972.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    57. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol. 1996 Jun; 70(6):3863-9. Sonza S, Maerz A, Deacon N, Meanger J, Mills J, Crowe S. PMID: 8648722.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCells
    58. Response: Attenuated HIV Vaccine: Caveats. Science. 1996 Mar 29; 271(5257):1791-2. Deacon NJ, McPhee DA, Crowe S, Learmont J, Mills J. PMID: 17812357.
      View in: PubMed   Mentions:    Fields:    
    59. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 1995 Nov 10; 270(5238):988-91. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J. PMID: 7481804.
      View in: PubMed   Mentions: 427     Fields:    Translation:HumansCells
    60. Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1. Virology. 1995 Sep 10; 212(1):58-68. Tachedjian G, Hooker DJ, Gurusinghe AD, Bazmi H, Deacon NJ, Mellors J, Birch C, Mills J. PMID: 7545854.
      View in: PubMed   Mentions: 15     Fields:    Translation:Cells
    61. HIV replication in chronically infected macrophages is not inhibited by the Tat inhibitors Ro-5-3335 and Ro-24-7429. J Leukoc Biol. 1994 Sep; 56(3):369-73. Dunne AL, Siregar H, Mills J, Crowe SM. PMID: 8083610.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    62. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol. 1994 Sep; 56(3):318-27. Crowe SM, Vardaxis NJ, Kent SJ, Maerz AL, Hewish MJ, McGrath MS, Mills J. PMID: 8083603.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    63. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1994 Jun; 38(6):1246-50. Safrin S, Elbeik T, Phan L, Robinson D, Rush J, Elbaggari A, Mills J. PMID: 8092821.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    64. Human immunodeficiency virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: a possible mechanism of T lymphocyte depletion in vivo. Clin Immunol Immunopathol. 1992 Nov; 65(2):143-51. Crowe SM, Mills J, Elbeik T, Lifson JD, Kosek J, Marshall JA, Engleman EG, McGrath MS. PMID: 1356673.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    65. Lack of evidence of occult human immunodeficiency virus in seronegative individuals at very high risk of infection. J Med Virol. 1991 Nov; 35(3):160-4. Crowe SM, Elbeik T, Ulrich PP, Mills J, Moss A. PMID: 1804928.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    66. Clinical and serologic features of herpes simplex virus infection in patients with AIDS. AIDS. 1991 Sep; 5(9):1107-10. Safrin S, Ashley R, Houlihan C, Cusick PS, Mills J. PMID: 1657040.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    67. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J Clin Oncol. 1991 Jun; 9(6):929-40. Kaplan LD, Kahn JO, Crowe S, Northfelt D, Neville P, Grossberg H, Abrams DI, Tracey J, Mills J, Volberding PA. PMID: 2033429.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    68. Human immunodeficiency virus: novel enzyme-linked immunoassays for quantitation of envelope glycoprotein 120. J Virol Methods. 1991 May; 32(2-3):287-301. Weiler BE, Schäcke H, Bachmann M, Brigido L, Gilbert M, Mills J, Matthes E, Forrest JM, Müller WE. PMID: 1874921.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    69. Mediators of fusion between HIV-infected macrophages and lymphoid cells. Adv Exp Med Biol. 1991; 300:57-66; discussion 67-9. Crowe S, Mills J, McGrath MS. PMID: 1781347.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    70. Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120. J Clin Microbiol. 1991 Jan; 29(1):142-7. Gilbert M, Kirihara J, Mills J. PMID: 1993748.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    71. Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells. AIDS Res Hum Retroviruses. 1990 Aug; 6(8):1031-7. Crowe SM, Mills J, Kirihara J, Boothman J, Marshall JA, McGrath MS. PMID: 1977427.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    72. Influenza in patients with human immunodeficiency virus infection. Chest. 1990 Jul; 98(1):33-7. Safrin S, Rush JD, Mills J. PMID: 2361409.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    73. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus. J Med Virol. 1989 Nov; 29(3):176-80. Crowe SM, McGrath MS, Elbeik T, Kirihara J, Mills J. PMID: 2533247.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    74. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes. J Clin Microbiol. 1989 May; 27(5):977-82. Ng VL, Chiang CS, Debouck C, McGrath MS, Grove TH, Mills J. PMID: 2787334.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    75. Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo. J Clin Invest. 1988 Dec; 82(6):2097-105. Locksley RM, Crowe S, Sadick MD, Heinzel FP, Gardner KD, McGrath MS, Mills J. PMID: 3264291.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    76. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. J Infect Dis. 1988 Oct; 158(4):862-5. Jacobson MA, Crowe S, Levy J, Aweeka F, Gambertoglio J, McManus N, Mills J. PMID: 2844921.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    77. Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses. 1987; 3(2):135-45. Crowe S, Mills J, McGrath MS. PMID: 3113464.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    78. The acquired immunodeficiency syndrome. Infection control and public health law. N Engl J Med. 1986 Apr 03; 314(14):931-6. Mills M, Wofsy CB, Mills J. PMID: 3456486.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    79. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet. 1985 Sep 14; 2(8455):586-8. Levy JA, Shimabukuro J, Hollander H, Mills J, Kaminsky L. PMID: 2863599.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    80. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol. 1971 Jul; 107(1):123-30. Mills J, Van Kirk JE, Wright PF, Chanock RM. PMID: 5091954.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    81. Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health. 1970 Sep; 21(3):347-55. Chanock RM, Kapikian AZ, Mills J, Kim HW, Parrott RH. PMID: 4323368.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsPHPublic Health
    82. Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. . 1969 Jun; 131(2):658-61. Kim HW, Bellanti JA, Arrobio JO, Mills J, Brandt CD, Chanock RM, Parrott RH. PMID: 4977750.
      View in: PubMed   Mentions:
    John's Networks
    Concepts (404)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑